INSUBCONTINENT EXCLUSIVE:
BEIJING: China's Clover Biopharmaceuticals said on Monday a booster shot of its Covid-19 vaccine candidate significantly increased antibody
response against the Omicron coronavirus variant from levels seen after two primary shots.
